BUSPH’s Program on the Economics and Epidemiology of HIV in Africa

For more than two decades, the HIV economics and epidemiology team in the Department of Global Health at Boston University’s School of Public Health has been a leader in applying the tools of health economics, epidemiology, and program evaluation to understanding the public health consequences of the HIV/AIDS epidemic in sub-Saharan Africa and evaluating the effectiveness and cost-effectiveness of program and policy responses. Much of this work has taken place in South Africa, in collaboration with our Johannesburg-based partner, the Health Economics and Epidemiology Research Office (HE²RO) of Wits University. Other studies have been conducted in Zambia, Malawi, Kenya, and elsewhere on the continent and globally.

Please follow the links below to learn more about our work under this program, the specific projects we have underway, and our related publications.

• Economics: Costs, Cost-Effectiveness, Budget Impact, and Benefits of HIV Treatment and Prevention

• Epidemiology: Burden, Risks, and Outcomes of HIV Treatment and Prevention

• Evaluations: Interventions to Improve Service Delivery

• Co-Morbidities: Related Work on Hepatitis C, NCDs, and Other Conditions